Industry News
Novavax vaccine demonstrates 89.3% efficacy
Novavax has announced that its protein-based COVID-19 vaccine candidate has demonstrated a vaccine efficacy of 89.3% in a Phase 3 clinical trial conducted in the UK. [ + ]
Day hospital group acquires majority stake in private hospital development
Cura Day Hospitals Group has acquired a majority stake in Somerset Private Hospital, which will provide locals with world-class health care close to home. [ + ]
Blood cancer burden on the rise
Blood cancers are now the second most diagnosed cancers in Australia and the second most common cause of cancer-related deaths, according to the Leukaemia Foundation. [ + ]
ANPC develops new COVID-19-detecting technology
A patent has been filed for advanced magnetic resonance technology that can detect the pathological signature of COVID-19 without relying on direct detection of the SARS-CoV-2 virus. [ + ]
Medical Training Survey reveals culture needs addressing
According to more than 21,000 doctors in training, the quality of their training is generally high, but concerns persist regarding the culture of medicine. [ + ]
COVID-19 may reduce male fertility
A German study indicates that COVID-19 infection can cause increased sperm cell death, inflammation and oxidative stress, resulting in lower sperm quality and potentially reducing fertility. [ + ]
UNSW team prints 'bones' with living cells
UNSW Sydney scientists have developed a ceramic-based ink that may allow surgeons in the future to 3D print bone parts complete with living cells. [ + ]
Taskforce ignores role of nurses in frontline care, says ACN
The Australian College of Nursing says the final recommendations of the MBS Review Taskforce perpetuate the under-representation of nurses in the workforce. [ + ]
Hospital pharmacists prepare for vaccine rollout
With COVID-19 vaccinations set to roll out in less than one month, Australia's hospital pharmacists are preparing for their central role in the administration process. [ + ]
Study predicts global cancer surgery surge
A modelling study led by UNSW Sydney predicts that global demand for cancer surgery will rise by 52% within two decades, with low-income countries bearing the greatest burden. [ + ]
Unchecked misinformation risks vaccine efforts
A newly formed coalition of health and technology experts is calling on the Australian Parliament to force Big Tech companies to reveal the true extent of COVID-19 misinformation. [ + ]
Immunotherapy trial holds hope for children needing stem cell transplants
A new immunotherapy treatment will be studied in clinical trials, with the aim of preventing dangerous side effects for children who have to undergo stem cell transplants. [ + ]
Report finds mobile tech making healthcare workers' jobs easier
Research reveals that more than 78% of Australian healthcare workers have been issued with new technologies, such as mobile devices, to support their duties during the pandemic. [ + ]
TGA approves Pfizer/BioNTech vaccine
The Australian Therapeutic Goods Administration (TGA) has provisionally approved the Pfizer/BioNTech COVID-19 mRNA vaccine, COMIRNATY. [ + ]
How soon will we reach herd immunity for COVID-19?
Achieving herd immunity for COVID-19 may be a challenge through current vaccination programs, research from the Imperial College London has found. [ + ]